Crowdonomics
All companies
BullFrog AI Holdings, Inc. logo

BullFrog AI Holdings, Inc.

Operating

Biotech · Gaithersburg, MD

Estimated pre-money ⓘ
$35.6M
As of Feb 2024 · from Private Offering (2024) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$16,015,900
Crowd $0 · Private $16.0M · 6 rounds since 2020
Latest share price
$5.2121
Private · Common Stock · Feb 2024 offering price

Financials

FY2018–FY2025 (no data for FY2020) · from SEC filings · hover any figure for its source
$0
−$253K
2018
$0
−$79K
2019
2020no data
−$586K
2021
$10K
−$2.8M
2022
$65K
−$5.4M
2023
−$7.0M
2024
$117K
−$6.5M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018 reviewed
FY2019 reviewed
FY2021 audited
FY2022 audited
FY2023 audited
FY2024 audited
FY2025 audited
Income statement
Revenue
$0
$0
—
$10,000
$65,000
—
$116,670
Cost of goods sold
$0
$0
—
$800
$5,200
—
$94,778
Gross margin
—
—
—
92%
92%
—
19%
Net income
-$253,155
-$78,758
-$585,840
-$2,802,487
-$5,355,869
-$6,993,647
-$6,498,068
Taxes paid
$0
$0
—
—
—
—
—
Balance sheet
Cash
$1,244
$5,394
$10,014
$57,670
$2,624,730
$5,435,983
$2,183,705
Accounts receivable
$0
$0
—
—
—
—
—
Total assets
-$1,244
$5,394
$10,014
$80,369
$2,776,586
$5,551,830
$2,808,351
Short-term debt
$114,409
$104,806
$34,000
—
—
—
—
Long-term debt
$0
$0
—
—
—
—
—
Total liabilities
$114,409
$104,806
$1,019,121
$3,137,721
$184,350
$588,090
$672,022
Other
Headcount
—
1
—
—
—
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$35.6M
est. pre-money
Private · Common · Feb 2024

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Jun 30, 2026
Preferred stock · 0.39%Common Stock · 99.6%
ClassOutstandingVotes / shareShare of totalLast price
Preferred stockpreferred73,449—0.39%—
Common Stock18,541,651—99.6%$5.21Feb 2024
Total18,615,100100%

Shares outstanding over timein today's share terms

19M9.3M0
Dec 2022Jun 2026
Common StockPreferred stockSeries A Convertible Preferred StockRound openedSplit / conversion

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Mar 19, 2026

  • Vininder Singh2,496,446 Common Stock19.5%of
  • Tivoli Trust904,391 Common Stock6.69%of
  • Jason D. Hanson57,813 Common Stock—of votes
  • Josh Blacher4,950 Common Stock—of votes
  • R. Donald Elsey57,813 Common Stock—of votes
  • William Enright62,813 Common Stock—of votes

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $6.5MEst. pre-money $35.6M
Raised $866KInvestors 7
Raised $150K
Reg CF · SAFE · Oct 2020Closedvia Funders USA, Inc
Raised $0 / $1.1M

Team

3 people
Vininder Singh
CEO and Chairman
Robert Alan Richardson
BOD
William Hirschman
BOD

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

7 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form 10-QAug 14, 20260001628280-26-057121
    EDGAR
  • Form 10-QMay 14, 20260001493152-26-023068
    EDGAR
  • Form 10-KMar 19, 20260001493152-26-011644
    EDGAR
  • Form 10-QNov 14, 20250001493152-25-023496
    EDGAR
  • Form 10-QAug 13, 20250001641172-25-023560
    EDGAR
  • Form 10-QMay 13, 20250001641172-25-009946
    EDGAR
  • Form 10-KMar 14, 20250001493152-25-010367
    EDGAR
  • Form 10-QNov 8, 20240001493152-24-044329
    EDGAR
Source: SEC EDGARCIK 0001829247NVShare price $5.2121Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.